Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Erectile Dysfunction × Genitourinary × Clear all

Phase

Status

Sponsor Class

OTHER 40 INDUSTRY 3 FED 2 OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1 Genitourinary 1

Conditions

Prostatic Neoplasms 74 Urinary Bladder Neoplasms 26 Carcinoma, Renal Cell 7 Prostatic Hyperplasia 5 Neoplasms 5 Disease 5 Carcinoma, Transitional Cell 5 Kidney Neoplasms 4 Testicular Neoplasms 3 Pain, Postoperative 3 Sleep Initiation and Maintenance Disorders 2 Recurrence 2 Penile Neoplasms 2 Pancreatic Neoplasms 2 Pain 2 Non-Muscle Invasive Bladder Neoplasms 2 Motor Activity 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Anxiety Disorders 2 Wilms Tumor 1 Vulvar Neoplasms 1 Vomiting 1 Uterine Cervical Neoplasms 1 Urologic Neoplasms 1 Urinary Tract Infections 1 Urinary Bladder Diseases 1 Triple Negative Breast Neoplasms 1 Testicular Germ Cell Tumor 1 Testicular Diseases 1

Interventions

Cell- and Tissue-Based Therapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01089387 2025-12-04

INSTIN

Institut National de la Santé Et de la Recherche Médicale, France

Phase 1/2 Completed

Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡